Human monoclonal antibodies against yellow fever virus and uses therefor
US12037384B2 · kind B2 · utility
0Cited by
0References
27Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 29, 2022 |
| Grant date | Jul 16, 2024 |
| Priority date | — |
| Expiry date | Jul 29, 2042 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure is directed to antibodies binding to and neutralizing Yellow Fever Virus and methods for use thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.